Home
/ Myrexis
/ Competitors

Myrexis Competitors and Similar CompaniesClear all

Myrexis's competitors and similar companies include Genocea Biosciences, Merrimack Pharmaceuticals and Oncopeptides.

	Myrexis Myrexis (formerly known as Myriad Pharmaceuticals) is a molecular biopharmaceutical company.	Genocea Biosciences Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer.	Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.	Oncopeptides Oncopeptides is a clinical development pharmaceutical company.
Founding Date	Founding Date 1999	Founding Date 2006	Founding Date 2000	Founding Date 2000
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations New York, US HQ	Locations Cambridge, US HQ	Locations Cambridge, US HQ	Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US
Employees	Employees N/A	Employees 593% decrease	Employees 2763% decrease	Employees 80
Valuation ($)	Valuation ($) 4.1 m	Valuation ($) 5.7 k	Valuation ($) 223.7 m	Valuation ($) 42.4 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $1.6m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) kr71.1m (FY, 2025)
Net income	Net income N/A	Net income ($33.2m) (FY, 2021)	Net income ($1.2m) (FY, 2023)	Net income (kr249.6m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 209.5m	Total funding raised $ 79.4m	Total funding raised N/A